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In the first paper of  this series  I it was  shown  that  the mouse thymus cell 
population is heterogeneous. Two general cell subpopulations were identifiable 
on  the  basis  of  average  density and  membrane antigen representation. The 
majority cell subpopulation was of high density in albumin gradients and had 
high TL,  G~x,  0,  and Ly antigen content but was low in H-2. A  minor sub- 
population, comprising less than 10%  of all cells, was of low density and low 
thymus antigen content but high  in H-2.  Evidence was  developed  that  this 
latter population is similar to that shown by others  to be cortisone- (1-8)  or 
irradiation-resistant (2). In this report the minor, low-density subpopulation is 
examined with respect to primary alloantigen recognition, both in vitro and in 
vivo, and to other attributes which appear to identify it as a relatively "pure" 
population of T  cells. 
Materials and Methods 
Animals.--Female CBA, A/J,  C57BL/6, and various F1 hybrid  mice employed ranged 
from 6--12 wk of age. These animals were either obtained directly from Jackson Laboratory, 
Bar Harbor,  Maine, or derived from inbred lines maintained in this laboratory, originating 
from Jackson stocks. Congenic C57BL/6-TL  + and C57BL/6-TL-  were generously supplied 
by Dr. E. A. Boyse of the Sloan-Kettering Institute for Cancer Research, New York. 
Preparation of Cells.--Thymus or spleen cells were taken after exsanguination via the ab- 
dominal aorta. As described previously,  1 special care was taken to exclude lymph nodes ad- 
jacent to thymus. Suspensions were prepared by gently pressing small fragments, suspended 
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in RPMI-1640  (Grand Island Biological  Company, Grand Island, N. Y.), through 60-mesh, 
stainless steel screens and passing the resultant suspension through 23- and 25-gauge needles. 
Bovine  Serum  Albumin  Gradient  Separution.--Bovine  serum  albumin  (BSA) 2 gradients 
were prepared by the method described in the previous paper.  1 Concentrations of the various 
gradients for thymus cells were as follows: A  layer, that above 23%; B  layer, above 27%; 
C layer, above 29%; D layer, above 35%. The gradients for spleen cells were: A layer, that 
above 23%; B  layer, above 26%; C layer, above 29%; D layer, above 35%. 
Preparation  of Alloanliserum.--Anti-O  C3H  serum was prepared  by  repeated intraperi- 
toneal injection of female CBA thymus cells into AKR females.  Anti-H-2  b was prepared and 
tested as described.  1 Anti-TL serum, prepared by injecting ASLI, and A-strain, TL  +, spon- 
taneous leukemia, into congenic TL- A-strain mice, was also obtained from Dr. E. A. Boyse. 
Treatment ~f Thymus Cells with  Various Antisera and Complement.--2  X  l0  s thymus cells, 
suspended in  10  ml  of  RPMI-1640,  were incubated with  10  ml of antiserum, diluted with 
RPMI-1640, and  10 ml of complement at 37°C for 45 rain. 1 After washing three times with 
RPMI-1640 the ceils were resuspeuded in medium. Viability was ascertained by trypan blue 
exclusicm after incubation and washing. Lyophilized guinea pig serum  (Grand  Island Bio- 
logical  Company)  was used as  a  source  of complement. This  serum was diluted  1:5  with 
RPMI-1640 and absorbed with 80 rag/5 ml special agar-Noble (Difco Labs., Detroit, Mich.) 
for 1 hr on ice, according to the method of Cohen and Schlesinger  (9). The mean survival of 
C57BL/6  cells  in  these experiments was  12.6%  (range:  10.5-16.5%)  after treatment with 
anti-0 C3H, diluted 1:100.  Treatment of C57BL/6 thymus cells with anti-H-2  ~', diluted 1:20, 
gave survival ranging from 60  to 63%.  Survival of C57BL/6-TI  +  cells ranged from 25  te 
28% after treatment with anti-TL, diluted 1 : 100. 
Cortisone  Treatment.--Cortisone  treatment  consisted  of  an  intraperitoneal  injection  of 
2.5  mg of cortisone acetate  (Cortone; Merck, Sharpe  & Dohme, West Point, Pa.)  per 20 g 
body weight 2 days before collection  of thymus and spleen cells. 
Graft-versus-llost  Reactions.--Adult  female  ('57BL/6  thymus  cells  or  CBA  thymus  or 
spleen cells were injected intraperitoneally into newborn (CBA  X  C57BL/6)Fa or  (CBA  ;K 
A/J)F1  mice.  8  days after cell injection the recipients were sacrificed,  and  spleen weights 
were determined and expressed as milligrams  per  I00  g  body weight. Controls  consisted of 
littermates injected with 0.1  ml of RPMI-1640. The spleen index was calculated as the  ratio 
of spleen weight/100 g body weight in experinrentals to that of controls. An index  over 1.30 
was taken as evidence of a positive graft-versus-host (GVH)  reaction  (10). 
In  Vitro Assays.--RPMI-1640  culture medium, to which 100 units of penicillin and  100 
/xg of streptomycin/ml with 5% heated (56°C, 30 rain)  human serum obtained from a single 
donor had been added, was employed throughout these experiments. The  technique, slightly 
modified from that previously reported from this laboratory (11), was as follows:  1-2  X  106 
reacting cells  were distributed to each  tube  (12  X  75  mm polypropylene  tubes; No.  2063 
Falcon  Plastics, Div.  of B-D  Laboratories, Inc., Los Angeles,  Calif.)  containing 0.5  ml  of 
culture  medium, incubated at  37°C,  loosely  capped, in  a  5%  CO2-air  atmosphere at  80% 
humidity for varying periods of time. 
For PHA or LPS stimulation 1.0 Izl of phytohemagglutinin (PHA-P; Difco Labs.) or  10 
gg  of Sahnonella typhimurium  type-7 endotoxin  (LPS)  (obtained from Dr.  J.  W.  Shands, 
Department  of  Immunology and  Medical Microbiology, University of  Florida  College  of 
Medicine), prepared according to the method of yon Westphal et al.  (12), was added to each 
tube containing 2 X  106  cells  and cultured  for 48  hr.  For mixed leukocyte cultures target 
cells were prepared by incubating 15  X  106 spleen cells/0.5 ml with 50 #g mitomycin-C/0.1 
ml  (Nutritional Biochemicals Corporation, Cleveland, Ohio)  at 37°C  for 30  min.  The cells 
were then  washed three  times with  RPMI-1640  and  resuspended in  culture  medium  at  a 
2 Abbreviations  used  in  this paper:  BSA,  bovine serum albumin;  GVH,  graft-versus-host; 
LPS,  Salmondla  typhimurium  type-7  endotoxin  (lipopolysaccharide);  PHA,  phytohemag- 
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concentration  of 4 X  106/ml. 1 million target cells in 0.25 ml were added to each tube (con- 
taining 1 X  106 reacting cells/0.25  ml)  before incubation and incubated for 72 hr. 
Assay of thymidine-~H incorporation  was made by adding 0.5 #Ci of tritiated thymidine 
(Schwarz Bio Research,  Orangeburg, N. Y.; specific reactivity, 1.9 Ci/Mmole, 1 #Ci/2 #1) to 
each tube for the final 24 hr of culture.  At the end of the appropriate incubation period the 
tubes were centrifuged at 1500 rpm, and the cell pellet was washed twice with 0.15 ~  NaC1 
and twice with trichloroacetic  acid at 4°C. The resultant precipitate was washed once with 
cold absolute methanol, air dried,  and allowed  to dissolve in 0.25 ml of Nuclear-Chicago 
solubilizer (Nuclear-Chicago  Corporation,  Des Plaines, IlL) for 2 hr at 45°C. 12 ml of scin- 
tillation fluid, p-bis-2(5-phenyloxazolyl)benzene 100  mg/ml, and 2,5-diphenyloxazole 5 g~ 
liter in toluene, were then added to the soluble precipitate. The solution was transferred  to 
screw-top vials and counted in a Beckman  Model LS-250 liquid scintillation counter (Beck- 
man Instruments, Inc., Fu]lerton,  Calif.) after 24 hr accommodation.  The data obtained are 
presented as mean values ±  standard error (SE) for at least four replicate tubes. Controls for 
mixed leukocyte cultures included tubes containing  reacting cells plus syngeneic mitomycin- 
treated target cells. 
RESULTS 
Functional  Attributes  of Thymus Subpopulations  Separated  on BSA  Density 
Gradienls.--Separation of thymus cells in discontinuous BSA gradients has been 
shown to yield a low-density, low 0-antigen-bearing subpopulation in which the 
cooperative recognition effect attributable to thymus cells and necessary to an 
antibody  response  to sheep erythrocytes is concentrated  (13).  The  antigenic 
properties of this minor subpopulation have been  characterized as being high 
in H-2  but low or completely deficient in the  thymus-associated TL and  Grx 
antigens.  This subpopulation  contained  some  0-antigen and Ly-A.2 and  thus 
resembled, except in density,  the T  lymphocyte population in  the periphery, 
rather than  the majority of cells in the thymus. It was of interest to examine 
this subpopulation further with respect to established T  cell functions. Primary 
alloantigen recognition was, therefore, measured in vivo by the GVH reactions 
evoked by various fractions of cells and in vitro by one-way mixed lymphocyte 
cultures in which cells from the various fractions were incubated with allogeneic 
target  cells. Data  illustrating the  results of in  vivo experiments are given in 
Table I. 
Cells from CBA whole thymus cell populations gave positive GVH reactions 
in very few instances. Regardless of the cell dose administered to the (CBA X 
A/J)FI  hybrids, mean  values were  below significance according to  Simonsen 
standards.  The  slightly lower incidence of GVH  reactivity in  those receiving 
larger rather than smaller numbers of whole thymus cells is unexplained. Sig- 
nificant  GVH  occurred  when  whole  C57BL/6  thymus  cells  were  given  to 
(CBA X  C57BL/6)F1 hybrids. Graft-versus-host  reactions in (CBA X  A/J)F1 
hybrids which received BSA gradient subpopulations of CBA thymus cells were 
positive only in those groups which received the B  layer. This was evident in 
the degree of positivity, the proportion of positive reactions, and  the average 
values at a  high level of significance as compared with those of the other frac- 
tions. Whole spleen cells evoked strong GVH reactions, as would be anticipated. 1464  THYMUS  T  CELL  FUNCTIONS 
TABLE  I 
Graft-versus-Host Reactions Evoked by BSA  Density Gradient Subpopulations of Thymus  or 
Spleen Cells  from CBA Mice* 
Source of injected 
cells 
Whole thymus 
Thymus cell 
fractions{: 
B 
C 
D 
Whole spleen 
SpleenAtions  cell frac- 
Mean %  ±  sE 
cells in fraction 
16.3  ±  2.5 
3,5.6  ±  2.9 
36.9  -4-  3.7 
12.5  -4-  2.8 
B 
C 
D 
42.3  -4-  3.8 
39.3  -4-  3.6 
5.8  ±  1.2 
No. of 
cells in- 
jected 
(X 106) 
8O 
20 
20 
20 
20 
10 
10 
10 
10 
10 
Spleen index  No. pos- 
itive/No. 
tested  Individual values  Mean~sE 
1.43,  1.24,  1.13, 
1.01,  0.98,  0.97, 
0.94,  0.90 
1.86,  1.41,  1.39, 
1.30,  1.24,  1.19, 
1.16,  1.13,  1.08, 
1.05,  1.03 
1.07  -4-  0.06 
1.25  -4-  0.07 
1.96,  1.81,  1.48, 
1.44,  1.33,  1.32 
1.27,  1.25,  1.14, 
1.05,  1.04 
1.26,  1.14,  1.12, 
1.09,  1.05,  1.02 
2.40,  2.10,  1.88, 
1.87,  1.83,  1.79, 
1.71,  1.70,  1.43, 
1.28,  1.19,  1.19 
1.48,  1.42,  1.41, 
1.29,  1.09,  1.07, 
0.80 
1.46,  1.32,  1.19, 
1.17,  1,02,  0.72 
1.62,  1.54,  1.46, 
1.34,  1.32,  1.27, 
1.19 
1.60,  1.56,  1.53, 
1.46,  1.45,  1.30, 
0.86 
1.55  ±  0.10 
1.15  -4-  0.04 
1.11  :i:  0.03 
1.69  -4-  0.09 
1.22  -4-  0.09 
1.14  ±  0.10 
1.39  -4-  0.05 
1.39  4-  0.09 
% 
% 
% 
* CBA whole spleen or thymus cells,  or BSA gradient cell fractions thereof, were injected 
i.p. into newborn (CBA X  A)F1 hybrid mice, and the spleen index was assayed 8 days later. 
Those indices greater than 1.30 are considered as positive in this assessment. 
:~ A layer (1.3  ±  0.3)  and pellet (8.5  -4- 2.1)  were imt tested for GVH reactivity. 
This capacity, however, was contained in the denser gradient fractions, C and 
D,  and  in  this  respect  differed from  the  low-density,  reactive  thynms  sub- 
populations. 
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for susceptibility to a lloantigen stimulation by mitomycin-trea  ted target cells as 
previously reported from this laboratory (14). Table II illustrates results  of 
such studies, in which C57BL/6 thymus cells were examined for in vitro reac- 
tivity to mitomycin-blocked CBA spleen cells and the T-dependent mitogen 
PHA. The data clearly indicate that thymic responsiveness to both PHA and 
alloantigens is highly concentrated and in some experiments limited to cells in 
]'ABLE II 
PHA and Primary A lloantigen Stimulation of Whole and BSA Gradient-Separated Subpopula- 
tions of C57BL/6 Thymus Cells* 
Ex-  Cells 
peri-  tested 
ment 
Tdr-aH incorporation -- mean 4- sE  Tdr-~H incorporation -- mean 4- sE 
In- 
cre-  C57BL/6  Incre-  Ratio: 
PHA added  meat  Ratio:  (mito)  CBA (mito)  meat of 
Unstimulated  (1/*1)  of  PHA/  target  target cells  ineorpo-  CBA/ 
incor-  control  ceils  ration  C57BL/6 
po- 
tation 
a  Whole  965  :/: 34 
thymus 
B  layers  665  -4-  27 
C layer  228  4-  6 
D  layer  170  4-  7 
b  Whole  3135 4-  142 
thymus 
B  layer~  1371 4-  85 
C layer  486  4-  155 
D  layer  293  :k: 52 
c  Whole  2007  4-  385 
thymus 
B  layer~  1263 4-  210 
C layer  425  4- 91 
D  layer  471  4-  77 
875  4-  74  --  0.9  148  4-  16  4,517  4- 254  4,369  30.5 
1243 q-  117  576  1.9  276  4-  29  14,374  4- 447  14,098  52,0 
276  4-  7  48  1.2  195  4- 36  951  4- 68  756  4.8 
150  4-  7  --  0.9  123  4-  29  144  4-  21  21  1.1 
1743 4-  81  --  0.6  390  4-  135  6,500  4- 301  6,110  16.7 
5305 4- 289  3943  3.9  603  4-96  27,610  4-  1,711  27,007  45.8 
430  4-  131  --  0.9  202  4-  73  872  4- 42  670  4.3 
260  4-  14  --  0.9  141  4-  15  1,124  4- 201  973  8.0 
1119 :]: 133  --  0.6  362  4-  76  5,752  4-  152  5,390  15.9 
3299  4-  367  2036  2.6  783  ~-  136  16,828  4-  1,196  16,045  21.5 
726  4-  109  301  1.7  303  4-  140  1,642  4-  144  1,339  5.4 
292  d:  83  --  0.6  240  4-  51  1,005  4-  72  764  4.2 
* C57BL/0 thymus,  either whole or separated  in discontinuous BSA density gradients,  was  cultured with 
either 1 #1 of PHA or 1 X  10  s allogeneic mitomycin-treated cells, and the resultant stimulation was assayed in 
terms of Tdr3H incorporation after 48 or 72 hr, respectively. The data are given as mean values -4- sE for four 
replicate tubes using 1 or 2 X  106 cells in the PHA reactions and 1 X  10  ~ reacting cells in the mitomycin reac- 
tions. In experiments b and c 2 X  106 reacting cells were employed for PHA responses. 
,~ The distribution of thymus cells in BSA gradients in the three experiments shown was: A layer (above 23% 
BSA),  1.3 :k: 0.4%  (no data given); B  layer  (above 27%),  16.3 =t= 3.9%; C  layer  (above 29%),  33.3 ±  4.1%; D 
layer  (above 35%),  38.2 -4- 3.6%;  pellet,  10.5 4- 2.2%  (no  data  given). 
the low-density B layer; reactivity was nearly absent from cells in the C and D 
layers. 
It would appear, then, that the limited capacity of whole thymus to react to 
alloantigens,  both in vivo and in  vitro,  is  related  to the representation of a 
minor subpopulation of B  layer-type cells diluted by the more numerous but 
nonreactive cell populations. The data in Tables II and III also show that the 
degree of PHA responsiveness in the B  layer, although exceeding that of the 
other fractions and of whole thymus, is less than that found here and previously 
(15, 16) in whole spleen populations taken from C57BL/6 mice. This suggests 1466  THYMUS  T  CELL  FUNCTIONS 
that PHA receptors in the membranes of thymus cells may have more limited 
representation than in similarly reactive cells in the periphery. It was concluded 
from  these experiments  that  two established  thymus-dependent  functions  of 
lymphoid cells are found in the minor, low-density thymus subpopulation which 
has, on the average, low representation of thynms-unique membrane antigens 
'FABLE III 
PHA and  Alloantigen  Stimulation  of C57BL/6  Spleen  Cells and  BSA  Gradient Subpopulations* 
peri-  / Ceils tested 
ment ! 
I 
--I  .... 
a  Whole 
spleen 
A layer 
+ 
B  layer 
C  layer 
+ 
n  layer 
b  Whole 
spleen 
A layer 
+ 
B  layer 
C  layer 
+ 
D  layer 
c  Whole 
spleen 
A  layer 
+ 
B  layer 
C  layer 
+ 
D  layer 
Pro- 
por- 
tion 
of 
cells 
in 
frac- 
tion 
/O 
13 
i5 
53 
18 
Tdr-3lI  incorporation -- mean =t= SE 
2  X  106 reacting cells  J 
!~ncre ! R  i 
PttA added  .  ot  PHA/ 
(1 ~1)  Imcor-[  n  I  (mito) 
pora-  co  -  target cells 
!tion  I  troll 
I  I 
Unstim- 
ulated 
13,138 =k 2931 3,302  4-  193 
33  j 
47 
4,330  ±  159 11,689  -k  989 
12 
6,503  ±  113 19,903 =l= 831 
I 
14,775  ::k: 389]  2,900  =~: 249 
22  i 
59  f 
I 4,436  :t= 428 12,873  ::t= 475 
14  [ 
626 ~  98  9,277  4-  1,016!  8,651 i  14.8 
4,751  ::t= 394  21096 ~  205  I  0.4 
J 
1,969  ::k 130113,936 :~  7261111'967!  7.1 
4,379  116,313  964  i,1,934i  37 
I 
Tdr-8H incorporation -- mean :t= SE 
I  X  106 reacting ceils 
CBA  (mito) 
target cells 
I 
i  311  ::~ 41  1,054  ::k 90 
1 
3526  ~:  471  4,294  ±  903 
[ 539  4-  104  2,416  =t= 212 
t 
1910  :~= 151  12,424 :~= 659  10,514 
(  I 
0.3  14407 ::t= 831  ]20,664  ~::  1,704  16,257 
7  359  '22,737  :t: 938  ,  2.7  {2539 ±  416  20,198 
113,40(I I  3.16391  J:  774 i41,506  ±  1,34535,115 
Jil  0.2  ¢']812° :t:  7,38142,66314- 5,83234,543 
8'437ii  2.9  5420  =I= 1180i45,917 ::t= 3,301  40,497 
I  J 
II .... -I  ment of i  Ratio: 
,incorpo-t  CBA/ 
I  ration  I C57BL/6 
I 
i-- 
J 
743  I  3.4 
I 
768  1.2 
1,877  ]  4,5 
6.5 
4.7 
9.0 
6.5 
5.3 
8.5 
* In these experiments  the reactions of C57BL/6 spleen cells, or those  of pooled A  +  B  and C  -t-  D  BSA gradient 
fractions thereof, were tested with either 1/xl of PfIA per culture or mitomycin-treated target cells. The  PHA  culture 
period  totaled  48 hr  and the  alloantigen  culture  period was 72  hr. 
and relatively great representation of membrane antigens found on T  lympho- 
cytes in the peripheral lymphoid system. 
Functional Attributes of Thymus  Cell Subpopulations  Resistant  to  Treatment 
with Various Anlisera and Complement.--In  the previous paper it was found that 
a variable population of thylnus cells remained after treatment of whole thymus 
with  relatively  dilute  anti-0,  anti-TL,  or  anti-H-2.  In  each  case  a  residual 
population  retained  reactivity  to  the  other  antisera,  indicating  some  inde- SUSUMU KONDA, YOSHINOBU NAKAO, RICHARD T.  SMITH  1467 
pendence in representation of susceptible antigenic structures in the membranes 
of  the  various thymus cell  subpopulations. The functional characteristics  of 
alloantigen recognition in vitro and in vivo and PHA responsiveness in sub- 
populations derived in a similar fashion were then examined. 
Tables IV, V, and VI illustrate experiments in which whole C57BL/6 thymus 
]'ABLE IV 
Graft-versus-Host  Reactions  Evoked  by  C57BL/6  Thymus  Cells Surviving  Treatment  with 
Anti-TL  Antl-O,  or Anti-H-2 b and  Complement* 
Source of injected cells 
Untreated thymus 
cells 
Thymus ceils 
treated with 
Anti-TL (1 : 100) 
Anti-0 (1 : 100) 
Anti-H-2  b (l :20) 
Average 
No. cells 
per 
thymus 
(x to  6) 
161 
150 
126 
140 
No.  of 
injected 
cells 
(× lO  6) 
20 
5 or 5.~ 
2 
4 
5 
6 
20 
Survival 
alter 
anti- 
serum 
treat- 
ment 
% 
25.0 or 
28.0 
13.0 
10.5 
16.5 
10.5 
60.0 to 
65.0 
Spleen  index 
Individual  values  Mean ~ sE 
2.43,  2.12,  2.01, 
1.79,  1.58,  1.52 
1.38,  1.38,  1.28, 
1.08,  1.05,  1.04, 
1.03 
2.45,  1.81,  1.79, 
1.75,  1.55,  1.39, 
1.18 
2.67,  2.31,  2.11, 
2.10,  1.52,  1.49, 
1.03 
2.66,  2.01 
2.14,  1.82,  1.60, 
1.46 
2.40,  2.12,  1.75 
1.19,  1.16,  1.11, 
1.08,  0.98,  0.92 
1.90  ±  0.14 
1.14  4- 0.07 
1.70  ±  0.15 
1.89  ±  0.21 
1.99  :t:  0.12 
1.07 ±  0.04 
No. pos- 
itive/No. 
tested 
% 
% 
% 
* C57BL/6  thymus  cells were treated  with  indicated  dilutions of  anti-TL,  anti-0,  or 
anti-H-2 b plus 1:5 guinea pig complement, incubated at 37°C for 45 rain, washed, and the 
residual cells or untreated thymus cells were injected into newborn (CBA X C57BL/6)FI 
hybrids. The spleen index was assayed 8 days later. A positive reaction was taken as a spleen 
index of 1.30 or greater. 
cells were treated with anti-TL, -0, or -H-2  u in various experiments. The func- 
tional  capacity  of  varying  numbers  of  the  resultant  cell  populations  was 
then  evaluated in terms of  the  ability to  evoke  GVH  reactions in (CBA  X 
C57BL/6)F1 hybrids, to  recognize mitomycin-C-treated CBA  alloantigens in 
vitro, or to be stimulated by PHA. 
Table IV shows  that  GVH reactivity evoked  by 2  X  107  C57BL/6 whole 1468  xmz~tus  T  CELL  I~UNCTIONS 
TABLE  V 
PtlA and Primary Alloantlgen  Responses of Cells Surviving  Treatment  of C57BL/6  Thymus Cells 
with Ant{-O or Anti-H-2  b and Complement* 
I Sur-  J 
I  J vival I 
Ex-  Treatment  of  after 
peri-] thymus cells] anti- i 
ment  tested  serum 
I  trea t- 
ment I 
h 
TdrAH  incorporation  -- mean ~  SE  ]  Tdr-SH incorporation  -- mean 4- s~ 
1-2  X  106  reacting cells  I  1 X  10  reacting 6 cells 
1 
Unstim-  PHA added 
ulated  (I gl)  I•iitl 
tio:'  C37BL/6 
Ra- 
PHA/  (mito) 
con-  I target cells 
trol 
I 
0.9  (  148  :~  16 
8,527  4.8  3488  4-  1809 
0.6  [  62  :t=5 
391  1.9  141  4-  19 
1,435  6.7  238  4-  19 
9!  1.1 
866  2.8 
33,055 /  17.7 
89  1.3  221  4-  121 
8~240  12.4  494  :~= 43 
--  0.7  123  4-  6 
503  3.5  131  4-  15 
CBA  (mito) 
target cells 
4,517  -4-  254 
33,017  :t=  1,5ll 
71  zk  7 
2,156  ~  117 
6,609  4-  1,095 
184  zk 33  139  4-  18 
inmInn!•i 
Ratio: 
CBA/ 
ration  C57BL/6 
a  Untreated 
Anti-0  18 
(1:100) 
Anti-H-2 b  61.5 
(1:2o) 
b  Untreated  -- 
Anti-0  6 
(1:100) 
Anti-H-2 b  60 
(l:20) 
c  Untreated 
Anti-0  10 
(1:100) 
d  Untreated  -- 
Anti-0  11.5 
(1:100) 
Anti-H-2 b  66 
(1:20) 
e  Anti-0  30.5' 
(1:200) 
956  zk 34  873  4-  74 
2268  ::k 970  10,795  :t=  802 
116  ==  7  71  =k 3 
460  :iz  21  851  :k  181 
250  :k: 26  1,685  4- 99 
124  4-  2  I  133  4-  11 
490  4-  61  1,356  ~  102 
1983  4-  104  35,138  z~- 2,595 
348  :t: 23  437  :t=  28 
727  4-  168  8,965  4-  383 
141  4-  21  98  :t= 3 
200  4- 28  703  ±  106 
4,369 
29,529 
9 
2,015 
6,371 
96  :t= 5  86  4-  13,859  -- 
897  4-  74  18,010  4-  17,103 
661  ±  63 
3,571  =l=  225 
171  4-  12 
762  4- 98 
440 
3,077 
48 
631 
30.8 
9.5 
1.1 
15.3 
27.8 
0.8 
0.9 
20.1 
3.0 
7.2 
1.4 
5.8 
* C57BL/6  thymus  cells were either  treated  with  the  indicated  dilutions  of anti-0  C3H  or  anti-H-2 b  plus  comple- 
ment  (1:5),  washed,  and  the  surviving subpopulation  stimulated  either  by  PHA  (1  p.l/tube)  or  mitomycin-treated 
syngeneic or allogeneic (CBA) cell preparations.  Tdr-3H incorporation  was assayed after  48 or 72  hr, respectively,  and 
the data  are expressed as mean incorporation  values =t= sE for four replicate  tubes. 
thymus cell  s was strong and significant, as compared with insignificant reactions 
after 5 X  10  0 cells. After treatment with anti-TL and complement the residual 
subpopulation evoked significant GVH reactions in  the  F1 host at  cell  doses 
one-fifth to one-fourth those required for whole thymus. After administration of 
as few as 2  X  10  6 of the survivors of anti-0 treatment,  GVH reactions were 
highly significant. 
Thus,  it may be roughly calculated that after  treatment with anti-TL the 
residual cell population had approximately the same GVH-inducing powers as 
2  X  10  7 whole thymus cells,  and  anti-0  treatment  gave residual  populations 
having the GVH equivalent of 5 X  10  7 whole thymus cells. In contrast, 3 X  10  ~ 
H-2b-treated  cells  failed  to  evoke  any  GVH  reactions.  These  data  strongly 
suggest that the subpopulation effective in evoking GVH reactions was rela- SUSUMU  KONDA,  YOSHINOBU  NAKAO,  RICHARD  T.  SMITH  1469 
TABLE  VI 
PHA  and  Primary  Alloantigen  Responses  of  Cells  Surviving  Treatment  of  C57BL/6/TL + 
Thymus Cells with Anti-TL and Complement* 
Treat- 
ment of 
Experi-  thymus 
merit  cells 
tested 
a  Un- 
treated 
Anti-TL 
b  Un- 
treated 
Anti-TL 
c  Un- 
treated 
Anti-TL 
ur- 
ival 
fter 
nti- 
TL 
eat- 
tent 
% 
24 
Tdr-3H incorporation -- mean :5:: SE 
2 X  106 reacting ceils 
Unstim-  PHA 
ulated  added 
(1 ~1) 
336  ±  10  183  ± 
406  ±  39  918  -4-  15~ 
386  -4-  15  380:5::  ~.~ 
288:5::  16  002:5::  1 [£ 
2596  ±  98  638  :5:: 53 
2483 4- 293  809  4-  152 
2782  ±  198  550  :5:: 37 
2056 :5:: 165  110  4-  177 
1978:5::  186  738  -4- 2 ~l 
1687 :5:: 117  482  :5:: 15¢ 
Tdr-~H incorporation -- mean +  sE 
1 X  l0  s reacting cells 
C57BL/6 
(mito) 
target 
cells 
06:t:2  4-~ 
97±8  ::[:1 
344-9  4-1 
084-8  ±~ 
28  ±  35  :t: 
92  ±  68  4- 
76  4-  152  ±  ] 
41  -4-  60  4- 
,07  4- 55  ±  4 
;47  ±  111  4- 
CBA (mito) 
target cells 
165 
1,454 
1,866 
2,057 
2,882 
2,286 
2,089 
14,100 
13,719 
14,254 
Incre- 
ment 
of in- 
corpo- 
ration 
52  59 
152  1,357 
166  1,732 
76  1,949 
218  2,554 
85  1,994 
165  1,713 
407  13,889 
480  13,112 
729  13,707 
Ratio: 
CBA/ 
C57BL/6 
1.1 
15.01 
13.9 
19.1 
8.8 
7.8 
8.6 
26.1 
22.6 
26.0 
* Thymus cells taken from C87BL/6-TL  + mice were incubated with anti-TL (1 : 100) plus 1:5 guinea pig com- 
plement for 45 rain at 37°C,  and the indicated proportions of surviving  cells were washed and tested for stimula- 
tion by PHA or mitomycin-treated allogeneic (CBA) or syngeneic cells. In each experiment shown the number of 
reacting cells was 1 or 2  X  106 per tube as indicated. Tdr-3H incorporation was assayed after 48 (PHA) or 72 hr 
(alloantigen) incubation, and the data are expressed as mean values ±  sE per tube for four replicate tubes. 
tively resistant to both anti-TL and anti-0 but required H-2 representation in 
order to function in this capacity. 
By a similar approach the effects of anti-0, -H-2  b, and -TL on the capabilities 
of residual  thymus cells to be stimulated  by PHA and by alloantigens were 
assessed. These experiments are illustrated by data given in Tables V and VI. 
As with  GVH reactions, PHA  and alloantigen stimulation of whole thymus, 
whether expressed as absolute incorporation per 106 cells,  increment of incor- 
poration, or ratio, was increased by treatment with  1:100 anti-TL or anti-0. 
In contrast, the subpopulation remaining after treatment with anti-H-2  b and 
complement had no residual function. 
Anti-0, diluted 1 : 100, appeared to have the effect of concentrating PHA- and 
alloantigen-reactive cells in the thymus by eliminating 90 % of cells,  the high-0 
majority cell subpopulation. At 1:200 dilution, however, anti-0 was much less 
effective in concentrating these functional activities above the activity in whole 
thymus, even though 70 % of the treated population was killed. At high concen- 
trations of anti-0 (1: 20-1:40)  the low-0 functional cells did not survive to be 
tested for their activity. These data show that 0 is probably necessary to T  cell 
functions but that it is a quantitative requirement. 1470  THYMUS  T  CELL  I~'UNCTIONS 
PHA  and  Primary Alloantigen  Responses of Thymus  or Spleen  Cells  Taken 
from Cortisot~e-Treated  Animals.--Membrane antigen patterns found in B layer 
density gradient subpopulations closely resemble those of the population which 
remains after cortisone treatment or irradiation, t It was of interest to determine 
whether functional characteristics of these subpopulations were also  identical. 
The reactivity of thymus cells from cortisone-treated and control  animals was 
compared with respect to PHA and to alloantigen stimulation; similar determi- 
nations  were made on spleen  cells from the  same animals.  In addition,  LPS 
reactivity,  a  non-thymus-dependent  function,  was  also  examined.  Data  il- 
lustrating findings in these experiments are shown in Tables VII and  VIII. 
PHA  and  alloantigen  responsiveness  of  thymus  cells  was  concentrated  by 
cortisone  treatment,  whether  judged  by absolute  incorporation per  10  8 cells, 
increment of incorporation, or the ratio. By comparison, spleen cells from the 
same animals were unaffected in  their  capacity to respond  to PHA or to  be 
stimulated by alloantigens. 
TABLE VII 
PIIA  and  Primary Alloantigen Responses of  Thymus Cells Taken from  Cortisone-Treated 
C57BL/6 Mice* 
Tdr-aH  incorporation -  mean 4- sE  ]  Tdr-3H  incorpo ration -- mean ±  SE 
2 X  106  reacting cells  I  1 X  10  ~ reacting cells  Mean 
Ex-  No.  of  ]' 
peri-  Group  thymus  i  i Incre- ' Rat'o"  ment  tested  ceils per  i  Incre-  Ratio: 
mouse  Unstimu-I  PHA added  'ment  IPHkC/'[  C57BL/6  [  ment  of  n-  o ''~  (mito)  CBA (mito)  of in-  CBA/B 
(X  10  ~)  lated  ]  (1 ~d)  corpo- l  ~rmn:  target cell [  target cells  corpo-  C576L/ 
ration  269  4-  31 
ration 
a  Un-  i  --  0.3  1  2,463  4-  898  2,194  9.2 
treated  '  9,010  6.7 
Corti-  3.1  1577 ±  68  10,587  ±  848  '17,606  i  3,380  16,656  18.5 
sone  I 
b  Un-  113.7  490  -4-  61  1,356  q-  102  [  866  2,8 
i 
treated 
Corti-  11.6  767  =5 2I  ]25,266  4-  3,325  24,499  32,9 
/  i 
sone  J  107 
Un-  i  153  2292 -4-  56  i  716  -4-  36  !  --  c  0,3  353  ±  3,302  4-  149  2,949  9.2 
treated 
Corti-  ]  5.25  862  =-  103  4,647  4-  804  i 3,785  5.4  425  d=  48  6,650  4-  426  6,135  15,4 
U ~vne°^n-  '  ~  ,  ill 
d  148  24.5  792  4-  141  1,222  :k  107  [  430  1.5  204  :k  20  4,990  4- 263  ,  4,786 
treated  165  5,478  -4-  490  [ 978  4-  103!  823  4-  114  --  0.8  373:5=  5,105  14.7 
Corti-  8.2  2169  ±  115  18,906  4-  2,617116,747  8.7  1157  4-  215[  18,383  4-  561  17,226  15.9 
[ 
sone  1965 
±  100 10,921  4-  937  8,956  i  5.6  980  4-  136 17,056  4-  1,459,  16,076  17.4 
1696 4-  185 16,587  -4-  3,057  14,891  [  9.8  998  ::k 77  19,169  4-  592  18,171  19.2 
* C57BL/6  mice  were  given 2.5  mg  cortisone/20  g  body  weight; 2  days  later  the  number  of  thymus  cells  was 
counted,  and  the  ceils  were  assayed  in  comparison  to  cells  from  untreated  controls  for  response  to  PHA  (1  #1) 
or  mitomycin-treated  allogeneic  (CBA)  or  syngeneic  target  cells.  Stimulation was  estimated  by  incorporation  of 
Tdr-ZH after 48 or  72  hr  of  incubation and  expressed  as  mean  values  4-  sE  for  four  replicate  tubes.  In  experiment 
a  the data represent parallel assays in du:dicate or tri)licate of a single pool of thymus cells. SUSUMU  KONDA~ YOSHINOBU  NAKAO~ RICHARD  T.  SMITH  1471 
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These data are consistent with the interpretation that reactive ceils within 
the  thymus  are  concentrated by  cortisone treatment,  perhaps  the  result  of 
selective destruction of the nonreactive majority of thymus cells. The PHA- and 
alloantigen-reactive cell populations present in the spleens of cortisone-treated 
animals were unaffected under these conditions. The non-thymus-dependent, 
LPS-reactive spleen subpopulation was slightly decreased in its capacity to be 
stimulated after cortisone treatment. These data are consistent with antigenic 
patterns indicating that the B  layer, low-density population of the thymus is 
both functionally and antigenieally equivalent to that remaining after steroid 
therapy. 
DISCUSSION 
The data presented in this and the preceding paper  1 add to evidence of the 
heterogeneity of the naouse  thymus cell population. Here it was shown that at 
least  two  subpopulations  can  be  identified  in  terms  of  immunocompetence 
toward alloantigens and receptivity to PHA stimulation. 
The major subpopulation,  which showed evidence of neither primary allo- 
antigen recognition in vivo or in vitro nor PHA stimulation in vitro, comprised 
80-90 % of thymic lymphocytes. This subpopulation is of high average density 
in BSA gradients, consists mostly of cells highly sensitive to anti-0 and anti-TL 
cytotoxicity, and disappears after cortisone treatment. This fraction also cor- 
responds to that shown to be highly sensitive to anti-Gix and anti-Ly sera and 
relatively insensitive to anti-H-2. 
The minor subpopulation was identified as having most or all of the properties 
of primary alloantigen recognition and PHA reactivity present in whole thymus. 
This fraction was of relatively low average density, contained little or no TL 
or G~x, was relatively insensitive to anti-0 or anti-TL and complement, and 
resisted cortisone treatment. The functional attributes examined in this popu- 
lation and those of whole thymus were concordantly abrogated by treatment 
with anti-H-2 and complement, whether the subpopulation was derived on the 
basis of average density (i.e. the B layer), its insensitivity to cortisone treatment 
in vivo, or by anti-0 and anti-TL treatment in vitro. This subpopulation prob- 
ably corresponds to the fractions having GVH reactivity described  by Dicke 
et al.  (17)  and to that having the T  cell cooperative effect for an  anti-SRBC 
response (13). 
The  various  means  used  for deriving  functional  subpopulations  from the 
thymus appear to depend upon concentrating the responsive cells by eliminating 
the majority which are inactive and which thereby dilute the active cells.  An 
alternate possibility, that the various treatments destroyed inhibitory cells in 
the major subpopulation,  seems  less  likely,  since the various functions were 
detected in in vivo tests as well as in vitro. However, in view of a possible sup- 
pressor role ascribed to thymus cells recently (18),  the possibility cannot be 
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The size of the thymus cell population recognizing alloantigen, as in the case 
of peripheral  lymphoid cells,  is  a  matter of considerable theoretical interest 
(19).  Limiting dilution data are not reported here; however, estimates can be 
made with respect to maximum numbers of alloantigen-reactive cells. Calculat- 
ing from the GVH capability of CBA thymus B layer cells, the active popula- 
tion consists of less than 10% of thymus cells, or less than 10 X  108 per thymus. 
This test for immunocompetence was across a relatively weak histocompatibility 
barrier (CBA reacting to [CBA X  A/J]F1 hybrids). When a C57BL/6 thymus 
subpopulation reacted to the (CBA X  C57BL/6)F1 hybrid in the GVH model 
or in vitro to CBA, the responsive population was contained in less than 1.6 % 
of all  thymus cells.  In  another context, less  than  12%  of the  13%  of  cells 
surviving anti-0 plus  complement gave strong  GVH reactivity. This is  con- 
sistent with the interpretation (14) that the representation of cells responding 
to stronger H-2 differences is larger than that responding to weak ones. Reac- 
tivity toward a  strong alloantigenic mosaic is  contained in less  than  1%  of 
thymus cells. At a practical level the minor thymus cell subpopulation yielded 
by treating whole thymus with 1 : 100 anti-0 and complement has proven to be 
the  most  pure  and  convenient  alloantigen-reactive T  cell  source  employed 
experimentally. 
Because average properties were studied, the individual properties of specific 
cells  from this functional subpopulation may only be inferred. Within  these 
limits  the  characteristics  of  the  low-density, immunocompetent cell  can  be 
adduced as (a) significant but low representation of 0-antigen, (b)  mandatory 
presence of the H-2 antigen, (c) relatively few PHA receptors, and (d) resistance 
to cortisone. TL is ostensibly not required, but the known propensity of this 
antigen to modulate in the presence of specific antibody (20) limits the validity 
of this conclusion. 
Peripheral T  cells are found in fractions of both low and high density (15); 
those of higher density are the more numerous, however. Therefore, the im- 
munocompetent subpopulation  of  the  thymus differs from a  portion  of  the 
peripheral  T  cell  subpopulation,  chiefly with respect  to average density and 
cell size. 
Since  0-  and  Ly antigen  representation  is  greater  in  the  high-  than  the 
low-density components in  the spleen,  it has been suggested that the minor 
competent subpopulation of the thymus is poised for entry into the peripheral 
pool  (21)  and  there increases in  density and  associated characteristics  as it 
accommodates to  this environment.  Memory cells,  defined as a  numerically 
augmented, specifically reactive subpopulation resulting from immunization, 
have not been identified in the mouse thymus. The one class of mouse peripheral 
T ceils known to represent memory cells, that population responding in vitro to 
purified protein derivative after bacille Calmette Gu6rin immunization (15, 22), 
was found to have high average density in the spleen. On the other hand, the 
only known class of peripheral T cells currently considered to be primary recog- 1474  THYMUS  T  CELL  ~FUNCTIONS 
nition cells is that responding to alloantigen in vitro. These cells were found in 
both high- and low-density fractions of the spleen; actually, they were more 
orevalent,  calculated  as  incorporation per  l0  s cells,  in  the  low-density  sub- 
population (Table III) (15). 
These  data  suggest  that  a  significant  representation  of  primary  antigen- 
reactive cells emerging from the th~xnus may actually retain low-density char- 
acteristics in  the peripheral lymphoid tissues for some time or until  specific 
antigenic encounter stimulates their expansion into a memory population. The 
recent report of Pelet et al.  (23)  provides some direct evidence favoring this 
hypothesis.  Thev  found  that  mice  responding  to  alloantigen  immunization 
initially had splenic cytotoxic lymphocytes of low density, but these were of 
higher density after prolonged stimulation. D.~lninski and Argyris  3 have found 
bone marrow T  cells in C57BL/6 mice which have significant 0-markers; these 
are also apparently of low density. 
These considerations lead  to the  concept that  the T  cell class includes  at 
least three or, perhaps, four subpopulations of lymphoid cells  defined on the 
basis of geography, density, antigenic characteristics, and functional attributes. 
Some properties of these tentative subpopulations are suggested in Table IX. 
Th is proposed as a  notation to cover all  cells found within the thymus;  Tp 
describes peripheral  T  cells.  Th;  (thynms incompetent)  is  the  dominant cell 
subpopulation in the th3nnus,  antigenically endowed but immunologically in- 
competent and of uncertain significance in the internal cellular ecology of the 
organ. Evidence exists that the Th; population provides precursor cells for the 
Th~ subpopulation (25, 26). Th, (thynms competent) is the minor subpopulation 
of the thymus which is,  by most criteria, imnmnologically competent, of low 
average density, low in thymus antigens, and requires the H-2 component. It is 
virgin with respect to antigen encounter and,  therefore, has no memory aug- 
mentation. Two subpopulations of Tp are proposed: Tp,, the virgin, antigen- 
reactive T  cell,  probably of low density and apparently identical to the Th,, 
except for distribution; and  Tp,,,  the peripheral high-density, memory T  cell 
population. These two cells probably also differ in 0 representation, Tp~ being 
higher on the basis of over-all subpopulation susceptibility to anti-0, t 
It seems probable, on the basis of these data and those published recently, 
that Th~ is the equivalent of the T,~, population of Cohen and Claman, 4 and that 
Th~ is equivalent to their T,~. subpopulation. The experiments reported here do 
not reveal any T,~, class of spleen T  cells as described by Cohen and Claman. 
The Tp, and Th, subclasses appear identical to the T~ class of Raft and Cantor 
(25), and  Tim seems to include their To class.  Bone marrow T  cells are of low 
0 content, low density, are cortisone resistant,  and are thus,  probably, of the 
Tp~ subclass. 
While  operationally  useful,  these  arbitrary  categories  will  doubtless  be 
:5 Dyminski, J., and B. Argyris. Personal communication  to the authors. 
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TABLE  IX 
Summary of Characteristics of Tentative Mouse T  Cell Subpopulations 
Property of subpopulation  Thi  Thc and Tpc  Tpm 
Distribution  Thymus cortex  Uncertain 
Size, appearance 
Relative density in 
BSA gradient 
Per cent of cells 
Small, lymphoid  Large, lymphoid 
cell  cell 
High  Low 
80-90% of thymus 
Cortisone effect in vivo  Sensitive 
Relative irradiation  Sensitive 
effect in vivo 
Membrane antigens 
0  High 
TL  High 
Gix  High 
Ly  High 
H-2  Low or absent 
PC. 1  Absent 
Functional attributes 
Primary alloantigen  No 
recognition 
PHA stimulation  No 
Cooperative effect--  No 
SRBC 
LPS stimulation*  No 
Thymus-depend- 
ent  areas  of  pe- 
ripheral  lymph- 
oid tissues 
Small lymphocytes 
High 
2-10% of thymus;  20-30%  of  spleen 
unknown pro-  or  lymph  node 
portion of pe-  cells 
ripheral T cells 
Insensitive  Insensitive 
Less sensitive  Less sensitive 
Low, but required  Low 
Low or absent  Absent 
Low or absent  Absent 
Low  Low 
Intermediate  High 
Absent  Absent 
Yes  Probable yes 
Yes  Yes 
Yes  Untested 
No  No 
* From reference 24. 
changed as population heterogeneity is further defined with  regard  to  those 
cells which are,  will be, or have been under thymus influence. The data  pre- 
sented here allow for experimental focus upon the relatively pure The subpopu- 
lation of T  cells as one easily obtained, having a  high degree of alloantigenic 
responsiveness, antigen sensitivity, defined membrane antigens, and free from 
contamination by B cells and other cells found in lymphoid tissues. This should 
permit  identification of  specific  antigen  receptors  and  clarification of  their 
origin, their differentiation history within the thymus, and the mechanism of 
their emergence and distribution. 
SUMMARY 
The  functional attributes of  minor subpopulations of  mouse  thymus cells 
derived  by  bovine serum  albumin density gradient centrifugation, cortisone 1476  THYMUS  T  CELL  t'IYNCTIONS 
treatment,  or  selective  depletion  by  anti-TL  or  anti-0  treatment  have  been 
examined.  A  subpopulation derived in each fashion contains the cells required 
to evoke graft-versus-host reactions in neonatal F1 hybrid recipients  and to be 
stimulated by alloantigens in vitro in one-way mixed blnphocyte cultures and 
by phytohemagglutinin. The functions of this subpopulation are abrogated by 
treatment with anti-H-2 plus complement and by high concentrations of anti-0. 
A  tentative ordering of the various thvmus cell suboopulations, on the basis of 
these and other data, is described. 
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